• 1
    Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in the community: the Whickham Survey. Clin Endocrinol (Oxf) 1977;7: 48193.
  • 2
    Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87: 48999.
  • 3
    Wiersinga WM. Adult Hypothyroidism. In: Thyroid Disease Manager, 2002. Available from: [Accessed November 5, 2005].
  • 4
    Hendrick V, Altshuler L, Whybrow P. Psychoneuroendocrinology of mood disorders. The hypothalamic-pituitary-thyroid axis. Psychiatr Clin North Am 1998;21: 27792.
  • 5
    Kaplan MM, Sarne DH, Schneider AB. In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clin Endocrinol Metab 2003;88: 454042.
  • 6
    Saravanan P, Chau WF, Roberts N, et al. Psychological well-being in patients on ‘adequate’ doses of 1-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57: 57785.
  • 7
    Toft AD, Beckett GJ. Thyroid function tests and hypothyroidism. Br Med J 2003;326: 2956.
  • 8
    Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003;88: 454350.
  • 9
    Owen PJ, Lazarus JH. Subclinical hypothyroidism: the case for treatment. Trends Endocrinol Metab 2003;14: 25761.
  • 10
    Vanderpump M. Subclinical hypothyroidism: the case against treatment. Trends Endocrinol Metab 2003; 14: 2626.
  • 11
    Cooper DS. Combined T4 and T3 therapy—back to the drawing board. JAMA 2003;290: 30024.
  • 12
    Walsh JP. Dissatisfaction with thyroxine therapy—could the patients be right? Curr Opin Pharmacol 2002;2: 71722.
  • 13
    Ladenson PW. Psychological wellbeing in patients. Clin Endocrinol (Oxf) 2002;57: 5756.
  • 14
    McMillan CV, Bradley C, Woodcock A, et al. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 2004;14: 91625.
  • 15
    Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med 1990;7: 44551.
  • 16
    Bradley C. The Diabetes Treatment Satisfaction Questionnaire: (DTSQ). In: BradleyC, ed., Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur: Harwood Academic Publishers, 1994; 11132.
  • 17
    Howorka K, Pumprla J, Schlusche C, et al. Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue. Qual Life Res 2001;9: 91530.
  • 18
    Barendse SM, Speight J, Bradley C. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure. Am J Kidney Dis 2005;45: 5729.
  • 19
    Woodcock A, Bradley C. Validation of the HIV Treatment Satisfaction Questionnaire. Qual Life Res 2001;10: 51731.
  • 20
    Woodcock A, Bradley C, Plowright R, et al. Patient experiences of treatment for diabetic retinopathy: development of a retinopathy-specific treatment satisfaction questionnaire. Diabet Med 2003;19(Suppl. 2):S10.
  • 21
    Tabachnik BG, Fidell LS. Using Multivariate Statistics. New York: Harper & Row, 1983.
  • 22
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16: 297334.
  • 23
    Todd C, Bradley C. Evaluating the design and development of psychological scales. In: BradleyC, ed., Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur: Harwood Academic Publishers, 1994.
  • 24
    Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill, Inc., 1994.
  • 25
    Kline P. A Handbook of Test Construction. London: Routledge, 1993.
  • 26
    Kline P. An Easy Guide to Factor Analysis. London: Routledge, 1994.
  • 27
    Tabachnik BG, Fidell LS. Using Multivariate Statistics (2nd ed.). New York: HarperCollins, 1989.
  • 28
    Flesch RF. A new readability yardstick. J Appl Psychol 1948;32: 22133.
  • 29
    Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8: 7991.
  • 30
    Bech P. Methodological issues in individual quality of life assessment. In: JoyceCR, O'BoyleCA, McGeeH, eds., Individual Quality of Life: Approaches to Conceptualisation and Assessment. Amsterdam: Harwood Academic Publishers, 1999.
  • 31
    Mitchell J, Bradley C. Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. Qual Life Res 2001;10: 46573.
  • 32
    Del Series Quijano T, Delgado C, Martinez Espinosa S, et al. Cognitive deficiency in mild hypothyroidism. Neurologia 2000;15: 1938.
  • 33
    Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Intern Med 1998;129: 14458.